Researchers from Case Western Reserve University found that the immune system of spinal cord injury patients can be controlled using a family of therapeutic stem cells known as multipotent adult progenitor cells (MAPC), The MAPCs have the ability to mediate…
Month: January 2016
Interleukin-37 promotes locomotor recovery in acute spinal cord injuries
An international collaboration of researchers has shown for the first time that Interleukin-37 suppresses the inflammatory response after a spinal cord injury and minimises spinal tissue degeneration and functional disabilities. Although IL-37 was identified 15 years ago, studying its function has proven difficult…
New method to promote regeneration of injured spinal cord nerve cells
A group of small molecule natural products possesses potent neurotrophic properties without some of the shortcomings of protein-based agents. Now, Dartmouth College (New Hampshire USA) researchers have discovered that one of their recently discovered chemical reactions is capable of producing some of…
Long-term change in respiratory function following spinal cord injury
Researchers in Melbourne have found that age at injury and BMI affect the decline of respiratory function over time. The study was published in Nature, Spinal Cord here.
Chronic pain and depression common in those with spinal cord injury
In a study published in Nature researchers investigate the epidemiology of pain types in patients with spinal cord injury (SCI) according to the International Spinal Cord Injury Pain (ISCIP) classification. Read more…
Nordic Life Science completes first trial of its Spinalon™ pill for chronic paralysis
Developed by Canadian researchers from Laval University and CHU de Québec, Spinalon is an oral pill composed of three active molecules capable together of triggering short bouts of locomotor-like activity in the legs of spinal cord injured patients who had been…